November 04, 2025

GLP-1s and Tirzepatide: Similar GI Risk

Real-world data show similar rates of severe GI events with semaglutide, dulaglutide, and tirzepatide, reinforcing comparable safety across agents in routine care.

Conexiant

November 03, 2025

Settlement Cash: Misused or Misread?

Opioid settlement funds were used for R&B concerts promoting addiction awareness in Irvington, New Jersey, highlighting broader debates over how opioid restitution money is spent nationwide.

KFF Health News

October 31, 2025

Single-Injection Omvoh Option Simplifies Ulcerative Colitis Care

The FDA approved Eli Lilly’s interleukin-23p19 antagonist Omvoh (mirikizumab-mrkz) as a once-monthly single-injection maintenance option for adults with moderately to severely active ulcerative colitis.

Conexiant

October 29, 2025

FDA Pushes Faster, Cheaper Route for Biosimilar Approval

The FDA released new draft guidance to streamline biosimilar development.

Conexiant

October 29, 2025

H-1B Visa Changes: Who Pays the Price?

New fee structure could hit hardest where physicians are needed most.

Conexiant

October 27, 2025

Lower GI mistakes: Postop Crohn's, vaccine gaps, colonoscopy errors

There is no routine colonoscopy. Focus on the basics to reduce the impact of inevitable mistakes, done reliably every time.

Conexiant

October 27, 2025

Why Open Access May Not Boost Citations

Researchers found that companion open access journals charge high publication fees yet yield fewer citations than traditional journals.

Conexiant

October 24, 2025

Endoscopist skill found to predict short-term post-colonoscopy cancer

In the short term, the quality of the endoscopist is a stronger driver of cancer risk than polyp characteristics.

Conexiant

October 24, 2025

Synbiotic Supplement Reduced Multiple Inflammatory Proteins

Butyrate rise corresponded with lower IL-6 during 6-week synbiotic supplementation.

Conexiant